These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Expression of cyclooxygenase-2 in bladder transitional cell carcinoma and the significance thereof]. Yu L, Chen XJ, Shi PQ, Ding Q, Sun CH, Liu GB, Shi DM, Huang YG. Zhonghua Yi Xue Za Zhi; 2008 Oct 21; 88(38):2683-4. PubMed ID: 19080686 [Abstract] [Full Text] [Related]
6. Expression of cyclooxygenase-2 in patients with bladder carcinoma. Yoshimura R, Sano H, Mitsuhashi M, Kohno M, Chargui J, Wada S. J Urol; 2001 May 21; 165(5):1468-72. PubMed ID: 11342898 [Abstract] [Full Text] [Related]
8. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications]. Wülfing C, Eltze E, Von Struensee D, Wülfing P, Bode ME, Bettendorf O, Piechota H, Hertle L. Aktuelle Urol; 2004 Aug 21; 35(4):331-8. PubMed ID: 15459875 [Abstract] [Full Text] [Related]
9. [Expression of apoptosis inhibitor gene Livin in bladder transitional cell carcinoma and clinical implication thereof]. Song T, Hong BF, Gao JP, Cai W, Wang CY. Zhonghua Yi Xue Za Zhi; 2007 Mar 27; 87(12):806-7. PubMed ID: 17565859 [Abstract] [Full Text] [Related]
12. Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder. Shariat SF, Kim JH, Ayala GE, Kho K, Wheeler TM, Lerner SP. J Urol; 2003 Mar 27; 169(3):938-42. PubMed ID: 12576817 [Abstract] [Full Text] [Related]
13. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma. Moussa M, Omran Z, Nosseir M, Lotfy A, Swellam T. APMIS; 2009 Jan 27; 117(1):45-52. PubMed ID: 19161536 [Abstract] [Full Text] [Related]
14. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof]. Zhou JT, Cai ZM, Li NC, Na YQ. Zhonghua Yi Xue Za Zhi; 2006 Jul 25; 86(28):1970-4. PubMed ID: 17064593 [Abstract] [Full Text] [Related]
16. Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging. Ribal MJ, Mengual L, Marín M, Algaba F, Ars E, Fernández PL, Oliva R, Villavicencio H, Alcaraz A. Anticancer Res; 2006 Jul 25; 26(1A):411-9. PubMed ID: 16475726 [Abstract] [Full Text] [Related]
17. Relation between cyclooxygenase-2 expression and clinicopathologic parameters with patient prognosis in transitional cell carcinoma of the bladder. Gurocak S, Sozen S, Erdem O, Ozkan S, Kordan Y, Alkibay T, Akyol G, Bozkirli I. Urol Int; 2006 Jul 25; 76(1):51-6. PubMed ID: 16401921 [Abstract] [Full Text] [Related]
18. [The clinical significance of expression of cyclooxygenase-2 gene in breast cancer]. Guo GL, Yao ZX, Wu J. Zhonghua Yi Xue Za Zhi; 2003 Oct 10; 83(19):1661-4. PubMed ID: 14642098 [Abstract] [Full Text] [Related]
19. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage. Caprodossi S, Lucciarini R, Amantini C, Nabissi M, Canesin G, Ballarini P, Di Spilimbergo A, Cardarelli MA, Servi L, Mammana G, Santoni G. Eur Urol; 2008 Sep 10; 54(3):612-20. PubMed ID: 17977643 [Abstract] [Full Text] [Related]
20. Cytochrome P450 isoenzyme mRNA expression pattern in human urinary bladder malignancies and normal urothelium. Brauers A, Manegold E, Buettner R, Baron JM, Merk HF, Jakse G. Cancer Detect Prev; 2000 Sep 10; 24(4):356-63. PubMed ID: 11059566 [Abstract] [Full Text] [Related] Page: [Next] [New Search]